Startups
Transforming patient care with 3D printed medical solutions tailored to individual needs. Explore how our technology empowers pharmacists and pharmaceutical manufacturing.
Overview
Location
France, Occitania, Montpellier
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 8, 2026 | PharmaTher Sets 3D Printed Medicine Roadmap, Targeting First CraftMake Orders This Quarter and a Rare Pediatric NDA by 2028 | Where can AI actually help your print workflow? Find out at AMA: Software, online on October 22nd. Specialty pharmaceutical company PharmaTher Holdings plans to take its first orders for the CraftMake pharmaceutical 3D printer in Q4 2026, t... |
| Oct 5, 2026 | MB Therapeutics Wins French Approval for 3D Printed Medicine Supply | French start-up MB Therapeutics has received authorization from the French National Agency for Medicines and Health Products Safety (ANSM) to manufacture semi-solid pharmaceutical cartridges for 3D printing solid oral dosage forms. The comp... |
| May 27, 2025 | Insight Surgery Raises $2.5M to Scale Personalized Surgical Solutions Across U.S. | Houston-based medtech company Insight Surgery has raised $2.5 million in a Series A equity round led by US venture capital firm Nodenza Venture Partners, positioning the company for its next phase of U.S. growth. The investment follows FDA ... |
| Mar 4, 2025 | VERIGRAFT Secures €1.2M Eurostars Grant for 3D Printed Vascular Graft Breakthrough | VERIGRAFT, a Swedish biotechnology company specializing in regenerative medicine, has been awarded a €1.2 million Eurostars grant for the PREPPER (PREcision Printed PERsonalized Tissue Therapies) project. The initiative is a collaboration w... |
| Mar 3, 2025 | The Future of Medicine: 3D Printing Takes Center Stage | In the heart of Montpellier, a revolution is brewing. MB Therapeutics, a startup with a vision, has secured €2 million in seed funding. This money is not just a lifeline; it’s a launchpad. The goal? To create the first pharmaceutical facili... |
| Feb 25, 2025 | MB Therapeutics €2 Million Seed Funding to Support Personalized Medicine Production | MB Therapeutics, a Montpellier-based startup with over 8 years of expertise in pharmaceutical 3D printing, has secured €2 million in seed funding to develop the first pharmaceutical facility designed to provide 3D printing compatible soluti... |
| Oct 24, 2023 | CurifyLabs launches GMP Pharma Inks for on-site 3D printing of personalized medicines | Pharmaceutical customization technology developer CurifyLabs has launched Good Manufacturing Practice (GMP) developed Pharma Inks for on-site production of patient-tailored and personalized medicines in pharmacies and hospitals. Unlike the ... |
| Oct 11, 2023 | MB Therapeutics uses 3D printing to create personalized medicine for children | Pharmaceutical start-up MB-Therapeutics is using its MED-U Modular 3D printer to offer personalized on-demand treatment to patients. The company’s collaboration with healthcare institutions, such as the University Hospital Center of Nîmes, ... |
| MB Therapeutics | “Transforming patient care with 3D printed medical solutions tailored to individual needs. Explore how our technology empowers pharmacists and pharmaceutical manufacturing.” |
Show more
Reviews 0
FAQ about MB Therapeutics
What has the press written about MB Therapeutics?
Parsers VC has collected 11 articles mentioning MB Therapeutics, among them “PharmaTher Sets 3D Printed Medicine Roadmap, Targeting First CraftMake Orders This Quarter and a Rare Pediatric NDA by 2028” (Oct 8, 2026) and “MB Therapeutics Wins French Approval for 3D Printed Medicine Supply” (Oct 5, 2026).
Is MB Therapeutics still active?
Yes, MB Therapeutics is active; its latest activity on Parsers VC dates from Oct 8, 2026.